Skip to main content

2019 review of QoF

Since the Quality and Outcomes Framework (QOF) was introduced, PCRS has engaged with the process of developing and shaping the respiratory indicators. The process of development has varied over the years, and is currently run by NICE, which develops indicators which are put forward to the negotiating committees for inclusion in the GMS contract in each of the four nations each year. 

In 2018 NICE undertook a major overhaul of the diabetes indicators, and these new indicators were introduced in April 2019.  They announced at the start of 2019 in a report on the GP contract  which followed the NHS long term plan, that the next therapy areas to review would be asthma, COPD and heart failure. PCRS has a seat at the table for the discussions on asthma and COPD indicators, as does AsthmaUK and BLF. 

This paper was prepared for the first review meeting led by NICE on February 13,2019 and was shared in advance with various stakeholders attending. It sets out what we believe were the important considerations at the start of the review process.